Multidisciplinary End-of-Life Care for a Patient with Amyotrophic Lateral Sclerosis Requesting Euthanasia
Lancet 402:484, Kruithof,W.J.,et al, 2023
Placebo-Controlled, Randomized, Double-Blind Study of IncobotulinumtoxinA for Sialorrhea
Neurol 92:e1982-e1991, Jost, W.H.,et al, 2019
Toxidrome Recognition in Chemical - Weapons Attacks
NEJM 378:1611-1620, Ciottone, G.R., 2018
IgLON5-mediated neurodegeneration is a differential diagnosis of CNS Whipple disease
Neurol 90:1113-1115, Morales-Briceno, H.,et al, 2018
Clinical Manifestations of the anti-IgLON5 Disease
Neurol 88:1736-1743,1688, Gaig, C.,et al, 2017
Clinicopathologic Conference, Botulism
NEJM 372:364-372, Case 3-2015, 2015
Non-Alzheimers Dementia 2 Lewy Body Dementias
Lancet 386:1683-1697, Walker, Z.,et al, 2015
Viral Infections of the Nervous System, Chronic Meningitis, and Prior Diseases, Rabies
Adams & Victors Principles of Neurology, Chp 33, pg 753, Ropper, A.H.,et al, 2014
Heterozygous de-Novo Mutations in ATP1A3 in Patients with Alternating Hemiplegia of Childhood:A Whole-Exome Sequencing Gene-Identification Study
Lancet Neurol 11:764-773, Rosewich,H.,et al, 2012
Anti-NMDA-Receptor Encephalitis: Case Series and Analysis of the Effects of Antibodies
Lancet Neurol 7:1091-1098, Dalmau,J.,et al, 2008
Managing Acute Organophosphorus Pesticide Poisoning
BMJ 334:629-634, Roberts,D.M.&Aaron,C.K., 2007
A Double-blind Placebo-controlled Trial of Botulinum Toxin B for Sialorrhea in Parkinson's Disease
Neurol 62:37-40, Ondo,W.G.,et al, 2004
A Randomized Trial of Botulinum Toxin A for Treatment of Drooling
Neurol 61:1279-1281, Lipp,A.,et al, 2003
Morvans Syndrome: Peripheral and Central Nervous System and Cardiac Involvement With Antibodies to Voltage-Gated Potassium Channels
Brain 124:2417-2426, Liguori,R., et al, 2001
Injections of Botulinum Toxin A Into the Salivary Glands Improve Sialorrhoea in Amyotrophic Lateral Sclerosis
JNNP 69:121-123, Giess,R. et al, 2000
Practice Parameter:The Care of the Patient with Amyotrophic Lateral Sclerosis (An Evidence-Based Review), Report of the Quality Standards Subcommittee of the AAN
Neurol 52:1311-1323, Miller,R.G.,et al, 1999
Clinicopath Conf
Rabies, Involving the Central and Peripheral Nervous Systems and Heart, Case 21-1998, NEJM 339:105-1, 2, 1, 1998
Gastrointestinal Dysfunction in Parkinson's Disease:Frequency and Pathophysiology
Neurol 42:726-732, Edwards,L.L.,et al, 1992
Clozapine, A Novel Antipsychotic Agent
NEJM 324:746-754, Baldessarini,R.J.&Frankenburg,F.R., 1991
Management of Injuries Due to Chemical Weapons
BMJ 302:129-130, Murray,V.S.G.&Volans,G.N., 1991
Abnormal Eye Movements Encountered Following Severe Envenomations by Centruroides Sculpturatus
Neurol 41:604-605, Clark,R.F.,et al, 1991
Envenomation by the Scorpion Centruroides Exilicauda (C Sculpturatus) :Severe and Unusual Manifestations
Pediatrics 87:930-933, Berg,R.A.&Tarantino,M.D., 1991
Wilson Disease:Clinical Presentation, Treatment, and Survival
Ann Int Med 115:720-726, Stremmel,W.,et al, 1991
Extrapyramidal Involvement in Rett's Syndrome
Neurol 40:293-295, FitzGerald,P.M.,et al, 1990
Dysphagia, Speech Disorders and Centrotemporal Spikes-Waves
Arch Francaises De Pediatrie 47:115-117, Boulloche,J.,et al, 1990
Clozapine in the Treatment of Psychosis in Parkinson's Disease
Neurol 39:1219-1221, Friedman,J.H.&Lannon,M.C., 1989
Prolonged Intermittent Drooling & Oromotor Dyspraxia in Benign Childhood Epilepsy with Centrotemporal Spikes
Epilepsia 30:564-568, Roulet,E.,et al, 1989
Numbness of Half of the Tongue
Can J Neurol Sci 13:107-108, Sadler, R.M.,et al, 1986
Neuroleptic Malignant Syndrome:A Pathogenetic Role for Dopamine Receptor Blockage
Neurol 31:132-137, Henderson,V.W.,et al, 1981
Diagnosis of Treatable Wilson's Disease
NEJM 298:1347, Cartwright,G.E., 1978
Drug Therapy, Clonazepam
NEJM 299:812-816, Brown,T.R., 1978